Effect of Renal Denervation on the Plasma Adiponectin Concentration in Patients with Resistant Hypertension.
adiponectin
renal denervation
resistant hypertension
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
08 Mar 2023
08 Mar 2023
Historique:
received:
09
01
2023
revised:
13
02
2023
accepted:
23
02
2023
medline:
30
3
2023
entrez:
29
3
2023
pubmed:
30
3
2023
Statut:
epublish
Résumé
(1) Introduction: Adiponectin is synthetized by white adipose tissue and has anti-diabetic, anti-atherosclerotic, anti-thrombotic, anti-inflammatory, and cardioprotective properties. In patients with arterial hypertension, plasma concentration of adiponectin is lower than in healthy subjects. Renal denervation, i.e., percutaneous ablation of fibers from the sympathetic nervous system located in the wall of the renal arteries by radio frequency waves, is a method of resistant arterial hypertension treatment. (2) The aim of this single center, interventional, clinical study was to assess the effect of renal denervation on the plasma adiponectin concentration in patients with resistant arterial hypertension. (3) Materials and methods: 28 patients (13 women, 15 men) aged 54.4 ± 9.2 years with resistant hypertension who underwent renal denervation using Simplicity catheters (Medtronic, Inc., Northridge, CA, USA) were enrolled in the study. Plasma adiponectin concentration was determined using the Human Adiponectin ELISA Kit (Otsuka Pharmaceutical Co, Tokyo, Japan) before the renal denervation and 6 and 12 months after this procedure. (4) Results: Blood pressure (BP) values before renal denervation and 6 and 12 months after this procedure were as follows: systolic BP 190.4 ± 24.5, 160.8 ± 14.5, 155.7 ± 17.9 mmHg (
Identifiants
pubmed: 36983117
pii: jcm12062114
doi: 10.3390/jcm12062114
pmc: PMC10052744
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical University of Silesia
ID : PCN-1-078/N1/K
Références
Eur Heart J. 2007 May;28(9):1162-9
pubmed: 17446227
Metabolism. 2006 Apr;55(4):478-88
pubmed: 16546478
Diabetes Care. 2003 Feb;26(2):285-9
pubmed: 12547850
JACC Cardiovasc Interv. 2021 Feb 8;14(3):304-315
pubmed: 33541541
Cardiovasc Drugs Ther. 2019 Apr;33(2):245-259
pubmed: 30747398
JAMA. 2003 Apr 9;289(14):1799-804
pubmed: 12684358
Exp Biol Med (Maywood). 2007 Mar;232(3):390-7
pubmed: 17327472
Eur J Endocrinol. 2005 Feb;152(2):233-40
pubmed: 15745931
Diabetol Metab Syndr. 2017 Jun 28;9:49
pubmed: 28670347
Nutrients. 2021 Apr 02;13(4):
pubmed: 33918360
Biochem Biophys Res Commun. 1999 Apr 2;257(1):79-83
pubmed: 10092513
FEBS Lett. 2001 Oct 26;507(2):142-6
pubmed: 11684087
Diabetes. 2002 Oct;51(10):2968-74
pubmed: 12351435
Hypertension. 2005 Jun;45(6):1088-93
pubmed: 15883229
Int J Mol Sci. 2019 Mar 08;20(5):
pubmed: 30857216
Diabetes. 2001 Sep;50(9):2094-9
pubmed: 11522676
Hypertens Res. 2005 Feb;28(2):141-6
pubmed: 16025741
Biochem Biophys Res Commun. 2004 Jan 30;314(1):151-8
pubmed: 14715259
Clin Hypertens. 2022 Apr 15;28(1):11
pubmed: 35422052
Sci Rep. 2018 Jan 10;8(1):406
pubmed: 29321603
Diabetes Care. 2002 Jun;25(6):971-6
pubmed: 12032101
Circulation. 2003 Feb 11;107(5):671-4
pubmed: 12578865
Diabetes Care. 2004 Oct;27(10):2392-7
pubmed: 15451906
Front Physiol. 2017 May 30;8:369
pubmed: 28611687
Cardiovasc Diabetol. 2021 Aug 19;20(1):170
pubmed: 34412646
Am J Cardiol. 2005 Oct 1;96(7):946-51
pubmed: 16188522
Vasc Health Risk Manag. 2022 May 13;18:375-386
pubmed: 35592729
J Hypertens Suppl. 2006 Mar;24(1):S31-8
pubmed: 16601571
Med Sci Monit Basic Res. 2017 Jan 12;23:1-7
pubmed: 28077838
J Bras Nefrol. 2020 Mar;42(1):67-76
pubmed: 31939995
J Clin Hypertens (Greenwich). 2020 Oct;22(10):1854-1864
pubmed: 32882101
JAMA. 2009 Jul 8;302(2):179-88
pubmed: 19584347
Heart. 2003 Jun;89(6):663
pubmed: 12748229
Int J Mol Sci. 2020 Dec 09;21(24):
pubmed: 33317050
Blood Press. 2004;13(4):236-42
pubmed: 15581338
J Clin Hypertens (Greenwich). 2009 Feb;11(2):61-5
pubmed: 19222669
Clin Cardiol. 2010 Jun;33(6):E61-5
pubmed: 20552610
Int J Mol Sci. 2020 Feb 28;21(5):
pubmed: 32121260
Biochem J. 2009 Dec 14;425(1):41-52
pubmed: 20001961
Am J Hypertens. 2005 Nov;18(11):1470-5
pubmed: 16280284
J Clin Endocrinol Metab. 2002 Dec;87(12):5662-7
pubmed: 12466369
Diabetes Care. 2006 Feb;29(2):195-201
pubmed: 16443859
Circulation. 2004 Dec 14;110(24):3687-92
pubmed: 15569835
Semin Dial. 2009 Jul-Aug;22(4):391-5
pubmed: 19708988
Semin Nephrol. 2013 Jan;33(1):2-13
pubmed: 23374889
Clin Nutr. 2021 Apr;40(4):1503-1509
pubmed: 33743285
J Hypertens. 2006 Mar;24(3):591-6
pubmed: 16467663
J Biol Chem. 2003 Nov 7;278(45):45021-6
pubmed: 12944390
Blood Press. 2008;17(1):50-4
pubmed: 18568692
Am J Hypertens. 2003 Jan;16(1):72-5
pubmed: 12517687
Am J Hypertens. 2007 Aug;20(8):875-82
pubmed: 17679036
Circ Res. 2004 Mar 5;94(4):e27-31
pubmed: 14752031
Diabetes Care. 2005 Jun;28(6):1419-24
pubmed: 15920062
Biochem Biophys Res Commun. 2003 Feb 21;301(4):1045-50
pubmed: 12589818
Obesity (Silver Spring). 2006 Jul;14(7):1132-41
pubmed: 16899794
J Hypertens. 2021 Jul 1;39(7):1293-1302
pubmed: 33710173
Diabetes. 2003 Mar;52(3):667-74
pubmed: 12606507
Int J Cardiol. 2006 Mar 22;108(1):96-100
pubmed: 16246439
J Am Coll Cardiol. 2005 May 17;45(10):1649-53
pubmed: 15893182
Physiology (Bethesda). 2021 May 1;36(3):134-149
pubmed: 33904786
Am J Med Sci. 2013 Jun;345(6):455-61
pubmed: 23123561
Obes Res. 2003 Sep;11(9):1048-54
pubmed: 12972674